Madrid, Spain

Guido S Bigatti



Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 37(Granted Patents)


Location History:

  • Buenos Aires, AR (2013)
  • Madrid, ES (2017 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Guido S Bigatti: A Pioneer in Controlled Release Dosage Forms**

Introduction

Guido S Bigatti is an esteemed inventor hailing from Madrid, Spain. With a total of six patents to his name, Bigatti has made significant contributions to the field of pharmacology, particularly in developing innovative dosage forms that enhance the effectiveness of medications.

Latest Patents

Among his most notable inventions is a dosage form that provides a controlled release of methylphenidate, a medication often used to treat attention deficit hyperactivity disorder (ADHD). This invention is designed to resist alcohol-related dose dumping, thereby ensuring that patients receive the therapeutic benefits of methylphenidate without the risk of compromised efficacy due to alcohol consumption. It also outlines methods for administering this inventive dosage form and treating conditions that respond therapeutically to methylphenidate.

Career Highlights

Throughout his career, Guido S Bigatti has aligned himself with reputable companies, including Osmotica Kereskedelmi és Szolgáltató Kft. and Osmotica Kereskedelmi Es Szolgáltató Kft. His work in these organizations has provided him with the platform to develop innovative solutions in drug formulation.

Collaborations

Collaboration is key to innovation, and Bigatti has worked alongside notable colleagues such as Joaquina Faour and Ana C Pastini. Together, they have contributed to advancements in pharmaceutical technology, exemplifying the importance of teamwork in driving innovation.

Conclusion

Guido S Bigatti's work exemplifies the spirit of invention, showcasing how targeted innovations can lead to better therapeutic outcomes for patients. His contributions to the field of controlled release dosage forms continue to impact the pharmaceutical industry and enhance the efficacy of essential medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…